
No. of Pages: 125 | Report Code: BMIRE00029015 | Category: Life Sciences
No. of Pages: 125 | Report Code: BMIRE00029015 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Clinical Trials Market – By Phase
1.3.2 South & Central America Clinical Trials Market – By Study Design
1.3.3 South & Central America Clinical Trials Market – By Indication
1.3.4 South & Central America Clinical Trials Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 PEST Analysis
4.2.1 South And Central America PEST Analysis
4.3 Experts Opinion
5.1 Market Drivers
5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6.1 South & Central America Clinical Trials Market Revenue Forecast and Analysis
7.1 Overview
7.2 South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
7.3.1 Overview
7.3.2 Interventional: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
7.4.1 Overview
7.4.2 Observational: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
7.5.1 Overview
7.5.2 Expanded Access: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 South & Central America Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
8.3.1 Overview
8.3.2 Phase III: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
8.4.1 Overview
8.4.2 Phase II: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
8.5.1 Overview
8.5.2 Phase IV: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
8.6.1 Overview
8.6.2 Phase I: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.1 Overview
9.2 South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
9.3.1 Overview
9.3.2 Autoimmune/Inflammation: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
9.4.1 Overview
9.4.2 Pain Management: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
9.6.1 Overview
9.6.2 CNS Condition: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
9.7.1 Overview
9.7.2 Diabetes: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
9.8.1 Overview
9.8.2 Obesity: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
9.9.1 Overview
9.9.2 Cardiovascular: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.10 Other
9.10.1 Overview
9.10.2 Other: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1 South & Central America Clinical Trials Market
10.1.1 Overview
10.1.2 South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)
10.1.2.1 Brazil: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Brazil: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 Brazil: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)
10.1.2.1.4 Brazil: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)
10.1.2.1.5 Brazil: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)
10.1.2.2 Argentina: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Argentina: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Argentina: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)
10.1.2.2.4 Argentina: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)
10.1.2.2.5 Argentina: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)
10.1.2.3 Rest of South & Central America: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South & Central America: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Rest of South & Central America: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)
10.1.2.3.4 Rest of South & Central America: Clinical Trials Market, by Study Design, 2020–2028 (US$ Million)
10.1.2.3.5 Rest of South & Central America: Clinical Trials Market, by Indication, 2020–2028 (US$ Million)
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12.1 IQVIA Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Parexel International Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Charles River Laboratories International Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 ICON Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 SGS SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Syneos Health Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Thermo Fisher Scientific Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6
12.7.7 Key Developments
12.8 Laboratory Corp of America Holdings
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. Brazil Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 4. Argentina Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Rest of South & Central America Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)
Table 8. Rest of South & Central America Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of South & Central America Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms
Figure 1. South & Central America Clinical Trials Market Segmentation
Figure 2. South & Central America Clinical Trials Market, By Region
Figure 3. South & Central America Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in South & Central America Clinical Trials Market
Figure 5. Argentina is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South And Central America: PEST Analysis
Figure 7. South & Central America Experts Opinion
Figure 8. Impact Analysis
Figure 9. South & Central America Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. South & Central America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. South & Central America Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. South & Central America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: South & Central America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South & Central America: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)
Figure 29. South & Central America: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. Brazil: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Argentina: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of South & Central America: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies Done by the Companies in the Market, (%)